Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

FATE

FATE THERAPEUTICS INC

CIK 0001434316 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.11
↑ 0.18 (6.14%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals, Options

Key stats

Market Cap
$362.50M
P/E Ratio
-2.79
EPS
-1.15
Dividend Yield
Not covered
52W Position
96%
Beta
1.92

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
2.02
P/S
57.39
EV/Revenue
51.13
ROE
-72.3%
Valuation data covers 8,500/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 96%
$0.91$3.21

Latest Financials

2025-12-31 FY
Revenue
$6.65M
Net Income
-$136.31M
Total Assets
$318.94M
Free Cash Flow
-$112.04M

Recent news